Details

Autor(en) / Beteiligte

• Aragie, Solomon
• Shiferaw, Ayalew
• Sata, Eshetu
• Hailu, Dagnachew
• Dagnew, Adane
• Zeru, Taye
• Abebe, Adisu
• Tadesse, Zerihun
• Wittberg, Dionna M.
• Thompson, Isabel J. B.
• Lietman, Thomas M.
• Nash, Scott D.
• Jensen, Kimberly A.
• Callahan, E. Kelly
• Keenan, Jeremy D.

Titel

Compliance with tetracycline eye ointment during annual mass drug administration for trachoma control in the Amhara region, Ethiopia

Ist Teil von

• Tropical medicine & international health, 2024-10, Vol.29 (10), p.869-874

Ort / Verlag

England: Blackwell Publishing Ltd

Erscheinungsjahr

2024

Quelle

Wiley Online Library Journals Frontfile Complete

Beschreibungen/Notizen

• Objectives A 6‐week course of tetracycline eye ointment is an alternative to single ‐dose oral azithromycin in annual mass drug administration for trachoma control. Compliance with the recommended tetracycline eye ointment regimen has not been well characterised when administered as part of a trachoma control program. Methods A routine mass drug administration for trachoma was carried out in 40 communities in the Amhara region of Ethiopia. Two tubes of tetracycline eye ointment, to be administered twice daily for 6 weeks, was offered to all children under 6 months of age, to pregnant women who declined to take azithromycin, and to all individuals with a macrolide allergy. Seven weeks following the mass drug administration, a treatment compliance survey was performed for all community members documented to have received tetracycline eye ointment during the mass drug administration. Results Of the 491 individuals documented as having received tetracycline eye ointment from the treatment records, 367 completed the survey, of which 214 recalled being offered tetracycline eye ointment. A total of 105 (49%) respondents reported taking ≥1 daily dose of tetracycline eye ointment on most days of the week for at least the first week. Only 20 (9%) respondents reported taking at least 1 tetracycline eye ointment dose per week for 6 weeks. The most common reasons for low compliance included ‘saving it for a future infection’ and ‘stopped because I (or my child) seemed healthy’. The odds of low compliance were greater for those who reported not having adequate counselling (e.g., odds ratio [OR] 5.3, 95% CI 2.5–28.9 when low compliance was defined as not taking a tetracycline eye ointment dose for most days of at least the first week). Conclusions Compliance with tetracycline eye ointment was low when administered by a trachoma program during a routine mass drug administration, especially for those reporting inadequate counselling. Further research with a larger sample size and varied settings is warranted to better understand and improve compliance.